Pharmaceutical Dissolution Testing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Services Method (In vitro, In vivo), By Dissolution Apparatus (Basket, Paddle, Others), By Dosage Form (Capsule, Tablets, Others), By Region and Competition, 2020-2030F

May 2025 | 180 pages | ID: PF1A72344D7CEN
TechSci Research

Abstracts

Market Overview

The Global Pharmaceutical Dissolution Testing Services Market was valued at USD 702.34 Million in 2024 and is projected t%li%reach USD 1134.14 Million by 2030, growing at a CAGR of 8.31% during the forecast period. As the pharmaceutical industry prioritizes drug quality, regulatory adherence, and therapeutic efficacy, the demand for dissolution testing services is on the rise. These services are vital in drug development and quality control, providing insights int%li%the dissolution rate, bioavailability, and in viv%li%performance of solid dosage forms. Dissolution testing simulates the release of a drug in the body, helping manufacturers ensure consistency, safety, and therapeutic effectiveness. Increasingly stringent global regulatory frameworks have made dissolution testing a mandatory standard, further driving market demand. Through continuous monitoring of drug dissolution profiles, pharmaceutical firms can refine formulations and manufacturing processes, contributing t%li%enhanced product reliability. As more complex and innovative drug formulations enter development, dissolution testing services are becoming indispensable in supporting regulatory submissions and batch-to-batch consistency, making them a critical component of pharmaceutical R&D and quality assurance.

Key Market Drivers

Rising Pharmaceutical R&D

The growth of pharmaceutical research and development is a key factor propelling the Global Pharmaceutical Dissolution Testing Services Market. With increasing investment in novel drug development and therapeutic innovation, the role of dissolution testing has become integral t%li%optimizing formulations, assessing drug bioavailability, and ensuring production consistency. The surge in new drug candidates across therapeutic areas demands robust testing solutions t%li%meet regulatory and clinical standards. According t%li%the OECD, global pharmaceutical R&D expenditure reached USD 129 billion in 2021, with the United States contributing the majority share. This upward trend is reinforced by rapid R&D expansion in countries like China, which recorded a 189% increase in pharmaceutical research spending between 2010 and 2019. As R&D activity accelerates globally, the need for specialized testing services, particularly in dissolution studies, is rising, ensuring compliance, safety, and therapeutic performance in increasingly complex drug products.

Key Market Challenges

Regulatory Compliance

Regulatory compliance remains a significant challenge for the pharmaceutical dissolution testing services market. With evolving guidelines from global authorities such as the U.S. FDA and EMA, testing laboratories must stay updated with the latest requirements for drug evaluation. Adhering t%li%these standards necessitates significant investment in training, advanced instrumentation, and meticulous documentation. Non-compliance can result in regulatory penalties, delays in product approvals, or product recalls, affecting a company’s market standing and operational costs. As compliance expectations grow more stringent, service providers must continuously adapt their processes, ensuring accuracy, traceability, and alignment with international regulatory frameworks. The constant evolution of compliance benchmarks places a considerable operational and financial burden on testing organizations, making regulatory alignment a critical success factor in the dissolution testing services market.

Key Market Trends

Increasing Drug Development Activities

The escalating pace of drug development is driving increased demand for pharmaceutical dissolution testing services. With the pharmaceutical industry expanding its focus on targeted therapies, biologics, and controlled-release formulations, the need for precise and reliable dissolution testing is more crucial than ever. These tests play a vital role in formulation development, quality control, and regulatory approval. Modern formulations, including nanoparticles and extended-release systems, require specialized dissolution assessments t%li%ensure accurate drug performance analysis. Regulatory agencies demand rigorous documentation of dissolution profiles during the drug approval process, reinforcing the value of expert testing services. Additionally, outsourcing testing t%li%specialized providers offers pharmaceutical companies cost efficiency, flexibility, and access t%li%technical expertise. This growing trend, fueled by a focus on time and resource optimization, is expected t%li%support the sustained expansion of the dissolution testing services market.

Key Market Players

• Intertek Group Plc
• Avivia BV
• Almac Group
• Agilent Technologies, Inc.
• Catalent, Inc.
• Therm%li%Fisher Scientific Inc
• Charles River Laboratories
• Cambrex
• Boston Analytical
• Pace Analytical Life Sciences

Report Scope:

In this report, the Global Pharmaceutical Dissolution Testing Services Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:

• Pharmaceutical Dissolution Testing Services Market, By Services Method:
• In vitro
• In vivo
• Pharmaceutical Dissolution Testing Services Market, By Dosage Form:
• Capsule
• Tablets
• Others
• Pharmaceutical Dissolution Testing Services Market, By Dissolution Apparatus:
• Basket
• Paddle
• Others
• Pharmaceutical Dissolution Testing Services Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Dissolution Testing Services Market.

Available Customizations:

Global Pharmaceutical Dissolution Testing Services market report with the given market data, TechSci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up t%li%five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Services Method (In vitro, In vivo)
  5.2.2. By Dissolution Apparatus (Basket, Paddle, Others)
  5.2.3. By Dosage Form (Capsule, Tablets, Others)
  5.2.4. By Company (2024)
  5.2.5. By Region
5.3. Market Map

6. NORTH AMERICA PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Services Method
  6.2.2. By Dissolution Apparatus
  6.2.3. By Dosage Form
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Pharmaceutical Dissolution Testing Services Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Services Method
      6.3.1.2.2. By Dissolution Apparatus
      6.3.1.2.3. By Dosage Form
  6.3.2. Mexico Pharmaceutical Dissolution Testing Services Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Services Method
      6.3.2.2.2. By Dissolution Apparatus
      6.3.2.2.3. By Dosage Form
  6.3.3. Canada Pharmaceutical Dissolution Testing Services Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Services Method
      6.3.3.2.2. By Dissolution Apparatus
      6.3.3.2.3. By Dosage Form

7. EUROPE PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Services Method
  7.2.2. By Dissolution Apparatus
  7.2.3. By Dosage Form
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. France Pharmaceutical Dissolution Testing Services Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Services Method
      7.3.1.2.2. By Dissolution Apparatus
      7.3.1.2.3. By Dosage Form
  7.3.2. Germany Pharmaceutical Dissolution Testing Services Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Services Method
      7.3.2.2.2. By Dissolution Apparatus
      7.3.2.2.3. By Dosage Form
  7.3.3. United Kingdom Pharmaceutical Dissolution Testing Services Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Services Method
      7.3.3.2.2. By Dissolution Apparatus
      7.3.3.2.3. By Dosage Form
  7.3.4. Italy Pharmaceutical Dissolution Testing Services Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Services Method
      7.3.4.2.2. By Dissolution Apparatus
      7.3.4.2.3. By Dosage Form
  7.3.5. Spain Pharmaceutical Dissolution Testing Services Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Services Method
      7.3.5.2.2. By Dissolution Apparatus
      7.3.5.2.3. By Dosage Form

8. ASIA-PACIFIC PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Services Method
  8.2.2. By Dissolution Apparatus
  8.2.3. By Dosage Form
  8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
  8.3.1. China Pharmaceutical Dissolution Testing Services Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Services Method
      8.3.1.2.2. By Dissolution Apparatus
      8.3.1.2.3. By Dosage Form
  8.3.2. India Pharmaceutical Dissolution Testing Services Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Services Method
      8.3.2.2.2. By Dissolution Apparatus
      8.3.2.2.3. By Dosage Form
  8.3.3. South Korea Pharmaceutical Dissolution Testing Services Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Services Method
      8.3.3.2.2. By Dissolution Apparatus
      8.3.3.2.3. By Dosage Form
  8.3.4. Japan Pharmaceutical Dissolution Testing Services Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Services Method
      8.3.4.2.2. By Dissolution Apparatus
      8.3.4.2.3. By Dosage Form
  8.3.5. Australia Pharmaceutical Dissolution Testing Services Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Services Method
      8.3.5.2.2. By Dissolution Apparatus
      8.3.5.2.3. By Dosage Form

9. SOUTH AMERICA PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Services Method
  9.2.2. By Dissolution Apparatus
  9.2.3. By Dosage Form
  9.2.4. By Country
9.3. South America: Country Analysis
  9.3.1. Brazil Pharmaceutical Dissolution Testing Services Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Services Method
      9.3.1.2.2. By Dissolution Apparatus
      9.3.1.2.3. By Dosage Form
  9.3.2. Argentina Pharmaceutical Dissolution Testing Services Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Services Method
      9.3.2.2.2. By Dissolution Apparatus
      9.3.2.2.3. By Dosage Form
  9.3.3. Colombia Pharmaceutical Dissolution Testing Services Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Services Method
      9.3.3.2.2. By Dissolution Apparatus
      9.3.3.2.3. By Dosage Form

10. MIDDLE EAST AND AFRICA PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Services Method
  10.2.2. By Dissolution Apparatus
  10.2.3. By Dosage Form
  10.2.4. By Country
10.3. MEA: Country Analysis
  10.3.1. South Africa Pharmaceutical Dissolution Testing Services Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Services Method
      10.3.1.2.2. By Dissolution Apparatus
      10.3.1.2.3. By Dosage Form
  10.3.2. Saudi Arabia Pharmaceutical Dissolution Testing Services Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Services Method
      10.3.2.2.2. By Dissolution Apparatus
      10.3.2.2.3. By Dosage Form
  10.3.3. UAE Pharmaceutical Dissolution Testing Services Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Services Method
      10.3.3.2.2. By Dissolution Apparatus
      10.3.3.2.3. By Dosage Form

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. PESTLE ANALYSIS

14. PORTER’S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. COMPETITIVE LANDSCAPE

15.1. Intertek Group Plc
  15.1.1. Business Overview
  15.1.2. Company Snapshot
  15.1.3. Products & Services
  15.1.4. Financials (As Reported)
  15.1.5. Recent Developments
  15.1.6. Key Personnel Details
  15.1.7. SWOT Analysis
15.2. Avivia BV
15.3. Almac Group
15.4. Agilent Technologies, Inc.
15.5. Catalent, Inc.
15.6. Thermofisher Scientific Inc.
15.7. Charles River Laboratories
15.8. Cambrex
15.9. Boston Analytical
15.10. Pace Analytical Life Sciences

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER